ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,347Medicare Part D Prescriptions Filled, Including Refills

Rank: 236 out of 2588

$694K Total Retail Price of All Prescriptions

Rank: 235 out of 2588

418 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 418 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

29% of this provider’s 418 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 8,591 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
HYDROCODONE-ACETAMINOPHEN 756 303 S3 1 7
FUROSEMIDE 460 333 2 5
AMLODIPINE BESYLATE 413 317 3 4
SIMVASTATIN 394 303 4 1
METFORMIN HCL 335 238 5 8
LISINOPRIL 294 203 6 3
CARVEDILOL 268 224 7 20
TRAMADOL HCL 267 184 8 19
ZOLPIDEM TARTRATE 226 114 9 24
OMEPRAZOLE 220 177 10 6
WARFARIN SODIUM 210 131 11 10
METOPROLOL TARTRATE 200 170 12 9
LEVOTHYROXINE SODIUM 199 152 13 2
PANTOPRAZOLE SODIUM 178 138 14 28
ENALAPRIL MALEATE 169 138 15 31
DIOVAN 151 88 16 29
AZITHROMYCIN 149 90 17 45
CLOPIDOGREL 147 123 18 30
HYDROCHLOROTHIAZIDE 143 93 19 13
ATORVASTATIN CALCIUM 140 99 20 11
PLAVIX 120 102 21 43
POTASSIUM CHLORIDE 114 93 22 15
CYCLOBENZAPRINE HCL 113 59 R 23 87
METOPROLOL SUCCINATE 108 75 24 12
NEXIUM 108 84 24 41
TAMSULOSIN HCL 105 101 26 23
HEPARIN SODIUM 100 100 27 79
GLIPIZIDE 100 80 27 44
LOSARTAN POTASSIUM 94 69 29 17
GABAPENTIN 93 77 30 18
GLYBURIDE 93 80 R 30 65
LEVETIRACETAM 89 68 32 90
ADVAIR DISKUS 87 37 33 48
FAMOTIDINE 84 53 34 36
PROAIR HFA 83 34 35 50
ACETAMINOPHEN-CODEINE 83 30 S3 35 80
SERTRALINE HCL 77 30 37 26
NIFEDIPINE ER 77 44 37 59
CITALOPRAM HBR 77 59 37 27
CRESTOR 75 74 40 25
ATENOLOL 75 71 40 14
ISOSORBIDE MONONITRATE ER 74 53 42 49
PREDNISONE 73 48 43 42
ALLOPURINOL 70 47 44 33
CARBIDOPA-LEVODOPA 70 48 44 83
NAMENDA 69 69 46 32
DOXYCYCLINE HYCLATE 67 38 47 151
LANTUS 66 36 48 47
HYDRALAZINE HCL 65 62 49 53
QUETIAPINE FUMARATE 61 22 50 74
CLONIDINE HCL 61 22 50 54
ALENDRONATE SODIUM 60 60 52 21
METFORMIN HCL ER 59 42 53 67
LIDODERM 54 30 54 86
JANUVIA 53 47 55 60
CLOTRIMAZOLE-BETAMETHASONE 52 43 56 155
PRAVASTATIN SODIUM 52 30 56 16
SYMBICORT 52 40 56 129
DONEPEZIL HCL 50 50 59 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.